FindTrial
Sign In

A Study comparing efficacy and safety of rosehip extract and ibuprofen in treatment of osteoarthritis

A STUDY OF EFFICACY AND TOLERABILITY OF ROSEHIP EXTRACT (GOPO) VS. IBUPROFEN (A NSAID) IN TREATMENT OF OSTEOARTHRITIS IN WEIGHT BEARING JOINTS.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013803
Enrollment
100
Registered
2018-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Osteoarthritis

Interventions

Intervention1: Rosehip Extract 250 mg orally twice daily for 3 months: The main active ingredient is GOPO.It inhibits chemotaxis and chemiluminescence of peripheral blood leucocytes without any toxici

Sponsors

GMC patiala
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patienta with confirmed diagnosis of Osteoarthritis

Exclusion criteria

Exclusion criteria: Major surgery of joints, Previous hypersensitivity to NSAIDS

Design outcomes

Primary

MeasureTime frame
Comparison of efficacy and tolerability of rosehip extract and ibuprofen in osteoarthritis on WOMAC scale and Visual analogue scaleTimepoint: 2 years—

Secondary

MeasureTime frame
The efficacy and tolerability of Rosehip Extract,The efficacy and tolerability of Ibuprofenon WOMAC and Visual analogue scaleTimepoint: 2 years—

Countries

India

Contacts

Public ContactHina Lal

GMC Patiala

vijayksehgal@yahoo.com9646732001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026